We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NET:NYSECloudflare, Inc. Analysis

Data as of 2026-06-14 - not real-time

$228.48

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Cloudflare (NET) is trading at $228.48, just below its 20‑day SMA of 231.4 but comfortably above the 50‑day SMA of 216.4, indicating a short‑term bullish bias. The 14‑day RSI sits at 49.6, suggesting neutral momentum, while the MACD histogram is negative and the signal line is bearish, warning of possible near‑term pull‑backs. Volatility is extreme at 106% over the past 30 days and beta is 1.64, underscoring high price swings relative to the market.
The latest earnings beat and an upgraded revenue outlook from Cisco have sparked a 4.5% price jump, and the company’s AI‑first restructuring plan (including a 1,100‑person workforce reduction) is being framed as a catalyst for margin improvement. However, fundamentals remain stretched: forward PE of 145x, price‑to‑book of 52.9x, and a DCF fair value of $78.9, implying the stock is significantly overvalued relative to intrinsic estimates. Analyst consensus remains a “Buy” with a median price target of $255, suggesting modest upside (~11%) but considerable downside risk if growth expectations falter.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish price above 50‑day SMA but bearish MACD signal
  • Recent earnings beat and revenue upgrade
  • High short‑term volatility and beta

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong revenue growth (33.5% YoY) and expanding AI‑driven product suite
  • Analyst consensus buy and median target price of $255
  • Increasing institutional interest (84 hedge funds, $3.55 B) indicating confidence

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Market leadership in cloud security and edge networking
  • Valuation far above DCF fair value, implying limited upside
  • Sustained high beta and volatility that could amplify downside in market stress

Key Metrics & Analysis

Financial Health

Revenue Growth33.50%
Profit Margin-3.72%
P/E Ratio145.4
ROE-5.88%
ROA-2.65%
Debt/Equity230.86
P/B Ratio52.9
Op. Cash Flow$615.7M
Free Cash Flow$755.0M
Industry P/E36.8

Technical Analysis

TrendBullish
RSI49.6
Support$192.80
Resistance$276.82
MA 20$231.44
MA 50$216.42
MA 200$207.07
MACDBearish
VolumeIncreasing
Fear & Greed Index89.86

Valuation

Fair Value$78.88
Target Price$243.11
Upside/Downside6.40%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta1.64
Volatility106.78%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.